• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Burden of disease. Methods of calculating disability from mental disorder.

作者信息

Andrews G, Sanderson K, Beard J

机构信息

Clinical Research Unit for Anxiety Disorders, St Vincent's Hospital, Sydney, Australia.

出版信息

Br J Psychiatry. 1998 Aug;173:123-31. doi: 10.1192/bjp.173.2.123.

DOI:10.1192/bjp.173.2.123
PMID:9850224
Abstract

BACKGROUND

The Global Burden of Disease studies are important because they encompass morbidity as well as mortality. Burden due to morbidity is calculated from incidence, duration and disability. There is a dearth of epidemiological measurements of disability.

METHOD

Data from a quasi-community sample (n = 1364) were analysed. Diagnoses of mental and physical disorders, and reports of disability, were based on established methods.

RESULTS

The disabilities reported in mental and physical disorders were comparable. Disability was correlated with comorbidity. The disability in mental disorders was examined by three methods: pure disorders, main problem and regression. It appears that major depression and substance disorder weights were overestimated, and anxiety disorder weights were underestimated in the Global Burden of Disease studies.

CONCLUSIONS

A method for disentangling the effects of concurrent comorbidity is presented. The size of burden attributed to mental disorders is of potential benefit for funding mental health services, It is important that we get the estimates right.

摘要

相似文献

1
Burden of disease. Methods of calculating disability from mental disorder.
Br J Psychiatry. 1998 Aug;173:123-31. doi: 10.1192/bjp.173.2.123.
2
The prevalence and burden of mental and substance use disorders in Australia: Findings from the Global Burden of Disease Study 2015.澳大利亚精神和物质使用障碍的流行程度和负担:来自 2015 年全球疾病负担研究的发现。
Aust N Z J Psychiatry. 2018 May;52(5):483-490. doi: 10.1177/0004867417751641. Epub 2018 Jan 11.
3
The burden of mental disorders in Victoria, 1996.1996年维多利亚州精神障碍的负担情况。
Soc Psychiatry Psychiatr Epidemiol. 2001 Feb;36(2):53-62. doi: 10.1007/s001270050290.
4
Register-based metrics of years lived with disability associated with mental and substance use disorders: a register-based cohort study in Denmark.基于登记的精神和物质使用障碍相关残疾生存年数的衡量指标:丹麦基于登记的队列研究。
Lancet Psychiatry. 2021 Apr;8(4):310-319. doi: 10.1016/S2215-0366(21)00029-8.
5
The burden of disease and injury in Australia.澳大利亚的疾病和损伤负担。
Bull World Health Organ. 2001;79(11):1076-84.
6
Burden of mental and substance use disorders in Indigenous Australians and Oceania.澳大利亚原住民和大洋洲人群的精神与物质使用障碍负担
Australas Psychiatry. 2015 Dec;23(6 Suppl):13-6. doi: 10.1177/1039856215608295.
7
The burden of mental disorders: a comparison of methods between the Australian burden of disease studies and the Global Burden of Disease study.精神障碍的负担:澳大利亚疾病负担研究与全球疾病负担研究方法的比较
Bull World Health Organ. 2000;78(4):427-38.
8
Reductions in quality of life and increased economic burden associated with mental disorders in an Australian adult sample.澳大利亚成年样本中与精神障碍相关的生活质量下降和经济负担增加。
Aust Health Rev. 2019 Jan;43(6):644-652. doi: 10.1071/AH16276.
9
Regional patterns of disability-free life expectancy and disability-adjusted life expectancy: global Burden of Disease Study.无残疾预期寿命和伤残调整生命年的区域模式:全球疾病负担研究
Lancet. 1997 May 10;349(9062):1347-52. doi: 10.1016/S0140-6736(96)07494-6.
10
Size and burden of mental disorders in Europe--a critical review and appraisal of 27 studies.欧洲精神障碍的规模与负担——对27项研究的批判性综述与评估
Eur Neuropsychopharmacol. 2005 Aug;15(4):357-76. doi: 10.1016/j.euroneuro.2005.04.012.

引用本文的文献

1
Mortality and mental health funding-do the dollars add up? Eating disorder research funding in Australia from 2009 to 2021: a portfolio analysis.死亡率与心理健康资金——资金充足吗?2009年至2021年澳大利亚饮食失调研究资金:一项投资组合分析。
Lancet Reg Health West Pac. 2023 May 16;37:100786. doi: 10.1016/j.lanwpc.2023.100786. eCollection 2023 Aug.
2
Disability during Early Pregnancy: Using the Sheehan Disability Scale during the First Trimester in Japan.孕早期的残疾情况:在日本孕早期使用希恩残疾量表
Healthcare (Basel). 2022 Dec 12;10(12):2514. doi: 10.3390/healthcare10122514.
3
Non-fatal disease burden for subtypes of depressive disorder: population-based epidemiological study.
抑郁症亚型的非致命性疾病负担:基于人群的流行病学研究
BMC Psychiatry. 2016 May 12;16:139. doi: 10.1186/s12888-016-0843-4.
4
Non-fatal burden of disease due to mental disorders in the Netherlands.荷兰因精神障碍导致的非致命疾病负担。
Soc Psychiatry Psychiatr Epidemiol. 2013 Oct;48(10):1591-9. doi: 10.1007/s00127-013-0660-8. Epub 2013 Feb 10.
5
Genetic association between RGS1 and internalizing disorders.RGS1与内化性障碍之间的基因关联。
Psychiatr Genet. 2013 Apr;23(2):56-60. doi: 10.1097/YPG.0b013e32835d7048.
6
Measurement of problems in activities and participation in patients with anxiety, depression and schizophrenia using the ICF checklist.使用国际功能、残疾和健康分类(ICF)清单对焦虑症、抑郁症和精神分裂症患者的活动和参与问题进行测量。
Soc Psychiatry Psychiatr Epidemiol. 2009 May;44(5):377-84. doi: 10.1007/s00127-008-0449-3. Epub 2009 Jan 27.
7
U.S. military mental health care utilization and attrition prior to the wars in Iraq and Afghanistan.伊拉克战争和阿富汗战争之前美国军队的心理健康护理利用情况与人员损耗情况。
Soc Psychiatry Psychiatr Epidemiol. 2009 Jun;44(6):473-81. doi: 10.1007/s00127-008-0461-7. Epub 2008 Dec 4.
8
Predictors of mental disorders and their outcome in a community based cohort.基于社区队列研究的精神障碍预测因素及其结局
Soc Psychiatry Psychiatr Epidemiol. 2007 Aug;42(8):623-30. doi: 10.1007/s00127-007-0182-3. Epub 2007 Jun 22.
9
Deriving utility scores for co-morbid conditions: a test of the multiplicative model for combining individual condition scores.推导共病状况的效用评分:对组合个体状况评分的乘法模型的检验。
Popul Health Metr. 2006 Oct 31;4:13. doi: 10.1186/1478-7954-4-13.
10
Assessing quality of life in eating disorder patients.评估饮食失调患者的生活质量。
Qual Life Res. 2005 Feb;14(1):171-8. doi: 10.1007/s11136-004-2657-y.